| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Medicine, Inflammation Research Center, University of Melbourne, and
The Ludwig Institute for Cancer Research, Royal Melbourne Hospital, Parkville, Victoria, Australia
The involvement of granulocyte-macrophage CSF (GM-CSF) in collagen-induced arthritis (CIA) was examined using GM-CSF-deficient mice. Although CIA is generally considered to be restricted to mice of the H-2q or H-2r haplotypes, we examined the role of GM-CSF in the CIA model using GM-CSF-deficient (-/-) and wild-type (+/+) mice on a C57BL/6 (H-2b) background. Mice were immunized by intradermal injection at the base of the tail with chick type II collagen followed by a repeat injection 21 days later. We found, based on both clinical and histologic assessments, that wild-type mice on this background developed severe CIA, while the GM-CSF-deficient mice had virtually no disease. Mice that were heterozygous for the GM-CSF gene (+/-) collectively displayed an intermediate response between those of the GM-CSF+/+ and GM-CSF-/- groups, suggesting a gene dosage effect. GM-CSF+/+ and GM-CSF+/- mice exhibited CIA responses ranging from mild (single digits) to severe swelling of all four paws, while in the few GM-CSF-/- mice that developed CIA the disease was confined to single digits. Despite the putative role of GM-CSF in dendritic cell development, GM-CSF-deficient mice exhibited both humoral and cellular (delayed-type hypersensitivity) responses to type II collagen; however, the cellular response was significantly reduced in the GM-CSF-deficient mice compared with the wild-type controls. These findings suggest that GM-CSF is required for CIA development in mice and support the idea that GM-CSF is a key cytokine in inflammatory joint disease.
This article has been cited by other articles:
|
|
 |
|
  M. S. Lee, H. S. Kim, J.-T. Yeon, S.-W. Choi, C. H. Chun, H. B. Kwak, and J. Oh GM-CSF Regulates Fusion of Mononuclear Osteoclasts into Bone-Resorbing Osteoclasts by Activating the Ras/ERK Pathway J. Immunol., September 1, 2009; 183(5): 3390 - 3399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. R. Hercus, D. Thomas, M. A. Guthridge, P. G. Ekert, J. King-Scott, M. W. Parker, and A. F. Lopez The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease Blood, August 13, 2009; 114(7): 1289 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. An, Q. Li, Z. Tu, H. Bu, C.-C. Chan, R. R. Caspi, and F. Lin Role of DAF in Protecting against T-Cell Autoreactivity that Leads to Experimental Autoimmune Uveitis Invest. Ophthalmol. Vis. Sci., August 1, 2009; 50(8): 3778 - 3782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Plater-Zyberk, L A B Joosten, M M A Helsen, M I Koenders, P A Baeuerle, and W B van den Berg Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor {alpha}-independent mouse model Ann Rheum Dis, May 1, 2009; 68(5): 721 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Sonderegger, G. Iezzi, R. Maier, N. Schmitz, M. Kurrer, and M. Kopf GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival J. Exp. Med., September 29, 2008; 205(10): 2281 - 2294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Enzler, S. Gillessen, M. Dougan, J. P. Allison, D. Neuberg, D. A. Oble, M. Mihm, and G. Dranoff Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of {beta} cells Blood, August 1, 2007; 110(3): 954 - 961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Plater-Zyberk, L A B Joosten, M M A Helsen, J Hepp, P A Baeuerle, and W B van den Berg GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice Ann Rheum Dis, April 1, 2007; 66(4): 452 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Li, T. Sai, M. Berger, Q. Chao, D. Davidson, G. Deshmukh, B. Drozdowski, W. Ebel, S. Harley, M. Henry, et al. Human antibodies for immunotherapy development generated via a human B cell hybridoma technology PNAS, March 7, 2006; 103(10): 3557 - 3562. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Timoshanko, A. R. Kitching, T. J. Semple, S. R. Holdsworth, and P. G. Tipping Granulocyte Macrophage Colony-Stimulating Factor Expression by Both Renal Parenchymal and Immune Cells Mediates Murine Crescentic Glomerulonephritis J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2646 - 2656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Cook, E. L. Braine, and J. A. Hamilton Stimulus-Dependent Requirement for Granulocyte-Macrophage Colony-Stimulating Factor in Inflammation J. Immunol., October 1, 2004; 173(7): 4643 - 4651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Kitching, A. L. Turner, T. Semple, M. Li, K. L. Edgtton, G. R. Wilson, J. R. Timoshanko, B. G. Hudson, and S. R. Holdsworth Experimental Autoimmune Anti-Glomerular Basement Membrane Glomerulonephritis: A Protective Role for IFN-{gamma} J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1764 - 1774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Willeke, B Schluter, H Schotte, M Erren, E Mickholz, W Domschke, and M Gaubitz Increased frequency of GM-CSF secreting PBMC in patients with active systemic lupus erythematosus can be reduced by immunoadsorption Lupus, April 1, 2004; 13(4): 257 - 262. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Bozinovski, J. Jones, S.-J. Beavitt, A. D. Cook, J. A. Hamilton, and G. P. Anderson Innate immune responses to LPS in mouse lung are suppressed and reversed by neutralization of GM-CSF via repression of TLR-4 Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L877 - L885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Murphy, C. L. Langrish, Y. Chen, W. Blumenschein, T. McClanahan, R. A. Kastelein, J. D. Sedgwick, and D. J. Cua Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation J. Exp. Med., December 15, 2003; 198(12): 1951 - 1957. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nakae, A. Nambu, K. Sudo, and Y. Iwakura Suppression of Immune Induction of Collagen-Induced Arthritis in IL-17-Deficient Mice J. Immunol., December 1, 2003; 171(11): 6173 - 6177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Cook, E. L. Braine, I. K. Campbell, and J. A. Hamilton Differing Roles for Urokinase and Tissue-Type Plasminogen Activator in Collagen-Induced Arthritis Am. J. Pathol., March 1, 2002; 160(3): 917 - 926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Kitching, X. Ru Huang, A. L. Turner, P. G. Tipping, A. R. Dunn, and S. R. Holdsworth The Requirement for Granulocyte-Macrophage Colony-Stimulating Factor and Granulocyte Colony-Stimulating Factor in Leukocyte-Mediated Immune Glomerular Injury J. Am. Soc. Nephrol., February 1, 2002; 13(2): 350 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. McQualter, R. Darwiche, C. Ewing, M. Onuki, T. W. Kay, J. A. Hamilton, H. H. Reid, and C. C.A. Bernard Granulocyte Macrophage Colony-Stimulating Factor: A New Putative Therapeutic Target in Multiple Sclerosis J. Exp. Med., October 1, 2001; 194(7): 873 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. H. Yang, P. Carmeliet, and J. A. Hamilton Tissue-Type Plasminogen Activator Deficiency Exacerbates Arthritis J. Immunol., July 15, 2001; 167(2): 1047 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gillessen, N. Mach, C. Small, M. Mihm, and G. Dranoff Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity Blood, February 15, 2001; 97(4): 922 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Biondo, Z. Nasa, A. Marshall, B. Hock Toh, and F. Alderuccio Local Transgenic Expression of Granulocyte Macrophage-Colony Stimulating Factor Initiates Autoimmunity J. Immunol., February 1, 2001; 166(3): 2090 - 2099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Wynn, K. Miyakawa, E. Miyata, G. Dranoff, M. Takeya, and K. Takahashi Role of Granulocyte/Macrophage Colony-Stimulating Factor in Zymocel-Induced Hepatic Granuloma Formation Am. J. Pathol., January 1, 2001; 158(1): 131 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Matthys, K. Vermeire, T. Mitera, H. Heremans, S. Huang, D. Schols, C. De Wolf-Peeters, and A. Billiau Enhanced Autoimmune Arthritis in IFN-{gamma} Receptor-Deficient Mice Is Conditioned by Mycobacteria in Freund's Adjuvant and by Increased Expansion of Mac-1+ Myeloid Cells J. Immunol., September 15, 1999; 163(6): 3503 - 3510. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
